HealthLynked Corp.
HLYK
$2.68
-$0.42-13.55%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -38.12% | -31.36% | -27.42% | -36.82% | -44.24% |
| Total Other Revenue | -51.88% | -30.15% | -95.29% | -15.01% | -31.41% |
| Total Revenue | -38.29% | -31.35% | -28.51% | -36.61% | -44.11% |
| Cost of Revenue | -57.89% | -48.92% | -39.54% | -36.05% | -36.56% |
| Gross Profit | 3.98% | 8.75% | -4.82% | -37.59% | -55.53% |
| SG&A Expenses | -15.57% | -33.02% | -37.61% | -36.30% | -24.16% |
| Depreciation & Amortization | -55.48% | -63.98% | -69.72% | -52.14% | -35.98% |
| Other Operating Expenses | -45.33% | -37.49% | -32.14% | -31.00% | -32.73% |
| Total Operating Expenses | -36.71% | -40.05% | -38.46% | -35.74% | -30.76% |
| Operating Income | 35.41% | 46.66% | 46.10% | 34.89% | 13.97% |
| Income Before Tax | 33.55% | 46.50% | 38.03% | -13.26% | -51.54% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 33.55% | 46.50% | 38.03% | -13.26% | -51.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 33.55% | 46.50% | 38.03% | -12.91% | -50.43% |
| EBIT | 35.41% | 46.66% | 46.10% | 34.89% | 13.97% |
| EBITDA | 33.95% | 46.13% | 45.60% | 33.88% | 17.13% |
| EPS Basic | 34.03% | 46.84% | 38.79% | -10.86% | -44.26% |
| Normalized Basic EPS | 45.46% | 42.54% | 28.79% | 13.94% | -10.57% |
| EPS Diluted | 45.83% | 55.87% | 49.03% | 13.60% | -76.36% |
| Normalized Diluted EPS | 45.46% | 42.54% | 28.79% | 13.94% | -10.57% |
| Average Basic Shares Outstanding | 1.33% | 0.73% | 1.42% | 2.82% | 4.91% |
| Average Diluted Shares Outstanding | 1.33% | 0.73% | 1.42% | 2.82% | 4.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |